Our results further demonstrate that the genetic LOAD background is sufficient to induce a CDH5 phenotype in BCECs and that the AD-related reduction in CDH5 can be modelled in vitro in a hiPSC-based version of the human BBB. This evidence concerns the gene CDH5 and Alzheimer disease.